Definitive Contract HT942525CE044
- Not listed
- Critical Innovations LLC has been awarded a $1.3 million firm fixed price definitive contract from the Department of the Army Medical Command under the Defense Health Agency Small Business Innovation Research Program Phase II solicitation number H2D-0130. This contract calls for Critical Innovations to complete medical research and development for its proposed "Eye-Aid System for Acute Ocular Injuries," with a period of performance through May 2026. As a total small business set-aside,...
- The Defense Health Agency awarded Physical Sciences Inc. (PSI), a small business research and development firm based in Andover, Massachusetts, a $1.1 million Phase II Small Business Innovation Research (SBIR) contract on May 25, 2023, for development of a multimodal optical imager designed to diagnose olfactory dysfunction. This total small business set-aside contract carries a firm fixed-price structure with a completion deadline of September 24, 2025. The award represents continuation of...
- The Department of the Army Medical Command awarded a $1.5 million firm fixed price contract to Infrascan Inc. to support research and development of a portable near-infrared technology for detection of traumatic brain injuries in operational environments. The contract is being carried out as part of the Small Business Innovation Research Program Phase II under solicitation H2-0631. Place of performance is Philadelphia, Pennsylvania. The 24-month contract period runs from June 2021 through August...
- This federal contract award is for a medical research and development effort focused on developing a clinical decision support tool for early detection of directed energy-induced injury to the retina. The contract was awarded by the Defense Health Agency to Oceanit Laboratories Inc., a small business technology development company, under the Small Business Innovation Research (SBIR) program. The contract is a firm-fixed-price purchase order with a potential value of $249,999.80 and a...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Defense Health Agency (DHA) to Sharp Vision Software LLC, a minority-owned small disadvantaged business. The $162,492.03 firm-fixed-price contract is for research and development of an "Intelligent Patient Simulation Platform" to support medical training. Sharp Vision Software has prior experience providing simulation technologies and training tools to the Department of Defense under the SBIR program,...
- The Defense Health Agency awarded a $249,959.61 Small Business Innovation Research (SBIR) Phase I contract to Vistendo Inc., a minority-owned, economically disadvantaged women-owned small business located in Arcadia, California. The contract is for the development of a Portable Oculomotor and Multisensing Assessment System (POMAS), which aligns with the agency's medical research and development efforts. SBIR contracts support small businesses in exploring innovative solutions for government...
- This is a Small Business Innovation Research (SBIR) Phase I research and development contract awarded by the Defense Health Agency (DHA) to SPZ Technologie LLC, a for-profit limited liability company. The $162,326.22 firm fixed-price contract is for the development of a "Novel Cell-Based Biosensor for Rapid Field Water Toxicity Detection" under Topic DHA191-006. The contract was set aside for small businesses and has a completion date of February 7, 2020. As an SBIR Phase I award, this...
- This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the Medical Command (MEDCOM) of the U.S. Department of Defense to Optowares Inc., a for-profit manufacturer of fiber optic equipment and components. The $1,099,951.23 firm-fixed-price contract is for the research and development of a "Battlefield Deployable Lab-on-a-Chip for Rapid MDR Bacteria Detection and Quantification in Infected Combat-Related Wounds." This project aims to develop an advanced...
- The Department of the Army Medical Command awarded Oceanit Laboratories Inc., doing business as Oceanit, a $1.1 million firm fixed price contract under the Small Business Innovation Research Program Phase II solicitation titled "Development of a Clinical Decision Support Tool for Early-Detection of Directed Energy Induced Injury to the Retina." Oceanit will perform the medical research and development work in Honolulu, Hawaii from April 2022 through August 2024. The contract has a...
- The Defense Health Agency awarded a $1.3 million Phase II Small Business Innovation Research (SBIR) contract to Tao Treasures, LLC, doing business as Nanobiofab, for development of TRISENSE, an artificially intelligent volatile organic compound sensing system designed for culture-free infection diagnosis in biofluids. This total small business set-aside contract, awarded on September 15, 2025, represents a continuation of the SBIR program's support for innovative medical technologies and is...
The Defense Health Agency awarded a $1.3 million Small Business Innovation Research (SBIR) Phase II contract to Innsight Technology, Inc., a small business, on September 15, 2025. The contract supports the development of a novel, handheld biosensor designed to detect full-thickness corneal injuries in real time for both civilian and military personnel. This innovation addresses a critical medical need in field and clinical settings where rapid, accurate diagnosis of corneal damage is essential for preventing vision loss and guiding appropriate treatment decisions. The work will be performed in Pittsburgh, Pennsylvania, with an anticipated completion date of January 14, 2028. The SBIR Phase II program represents a significant investment in early-stage technology development, enabling small businesses to advance promising innovations from initial proof-of-concept toward commercialization. This firm fixed-price, definitive contract reflects the Defense Health Agency's commitment to leveraging private sector innovation to improve medical diagnostics and healthcare outcomes for the military and veteran populations. The handheld biosensor technology, if successfully developed, could provide forward-deployed medical teams and emergency departments with an objective diagnostic tool for rapidly assessing corneal injuries, potentially transforming the standard of care in ophthalmic trauma management.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $617.8k | 9/9/25 |